Gabelli Funds’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Gabelli Funds’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-118,000	Closed	-$5.1M	–	1176
2015 Q3	$5.1M	Buy	118,000 +27,000	+30%	+$1.14M	0.03%	551
2015 Q2	$3.85M	Hold	91,000	–	–	0.02%	641
2015 Q1	$3.53M	Hold	91,000	–	–	0.02%	669
2014 Q4	$3.06M	Buy	91,000 +2,000	+2%	+$70.6K	0.01%	703
2014 Q3	$3.12M	Buy	89,000 +3,000	+3%	+$103K	0.02%	698
2014 Q2	$2.83M	Hold	86,000	–	–	0.01%	719
2014 Q1	$3.17M	Sell	86,000 -8,000	-9%	-$294K	0.02%	685
2013 Q4	$3.61M	Sell	94,000 -74,500	-44%	-$2.35M	0.02%	643
2013 Q3	$4.62M	Sell	168,500 -109,148	-39%	-$2.59M	0.03%	575
2013 Q2	$5.83M	Buy	+277,648	New	+$5.42M	0.04%	499

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Gabelli Funds's WX Position: Q4 2015 in Review

Gabelli Funds sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 118,000 shares — an estimated $5.1M sold.

Gabelli Funds first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $5.83M in Q2 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Gabelli Funds reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Gabelli Funds sold 118,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $5.1M.
Gabelli Funds first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
Gabelli Funds's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $5.83M in Q2 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Gabelli Funds's 13F filing for Q4 2015, filed 5 Feb 2016.